Clinical Trials on Heterozygous Familial Hypercholesterolemia
Total 2112 results
-
University of ReadingMedical Research CouncilCompletedHypercholesterolemiaUnited Kingdom
-
Clinical Research Center for End Stage Renal Disease...Ministry of Health & Welfare, KoreaCompletedHypercholesterolemiaKorea, Republic of
-
Durham VA Medical CenterCompleted
-
SanofiTerminatedHypercholesterolemiaUnited States, France, Canada, Russian Federation, Ukraine, Netherlands, Bulgaria, Belgium, Czech Republic, Israel, Slovakia, Australia, South Africa
-
USDA Beltsville Human Nutrition Research CenterCompletedHypercholesterolemiaUnited States
-
Yonsei UniversityCompletedHypercholesterolemiaKorea, Republic of
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolemiaSweden, Germany, Russian Federation, Denmark, Israel, South Africa, Spain, Hungary, United States, Colombia, Czech Republic, Argentina, Belgium, Bulgaria, Canada, Chile, Finland, France, Italy, Mexico, Netherlands, Norway, Poland, Por... and more
-
Alnylam PharmaceuticalsThe Medicines CompanyCompletedHypercholesterolemiaUnited Kingdom
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolemiaUnited States, Belgium, Finland, Netherlands
-
SanofiRegeneron PharmaceuticalsCompleted
-
SanofiRegeneron PharmaceuticalsCompleted
-
Inner Mongolia Yili Industrial Group Co., LtdCompletedHypercholesterolemiaChina
-
US Department of Veterans AffairsCompletedHypercholesterolemiaUnited States
-
Daiichi Sankyo, Inc.CompletedHypercholesterolemiaUnited States
-
Gachon University Gil Medical CenterCompleted
-
IlDong Pharmaceutical Co LtdUnknownHypercholesterolemiaKorea, Republic of
-
Micropharma LimitedCompletedHypercholesterolemia
-
Chonbuk National University HospitalCompleted
-
Genzyme, a Sanofi CompanyManipal Acunova Ltd.Completed
-
Pin Siang Medical Biotechnology Co., Ltd.UnknownHypercholesterolemiaTaiwan
-
University of JenaGerman Federal Ministry of Education and ResearchCompletedHypercholesterolemiaGermany
-
Bristol-Myers SquibbTerminatedHypercholesterolemiaGermany, Canada
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolemiaUnited States
-
Bronx VA Medical CenterCompletedHypercholesterolemiaUnited States
-
Maastricht University Medical CenterCompleted
-
Meir Medical CenterUnknownHypercholesterolemiaIsrael
-
Astellas Pharma IncCompleted
-
Ziv HospitalMerck Sharp & Dohme LLCCompletedHypercholesterolemiaIsrael
-
AstraZenecaClinArt Company & Signen Clinical DiscoveriesCompletedHypercholesterolemiaSaudi Arabia
-
Instituto Aragones de Ciencias de la SaludHospital Miguel ServetCompleted
-
Maastricht University Medical CenterRaisio GroupCompleted
-
Micropharma LimitedCompletedHypercholesterolemia
-
TakedaCompletedHypercholesterolemia
-
TakedaTerminatedHypercholesterolemiaUnited States, South Africa, Canada
-
TakedaTerminatedHypercholesterolemiaUkraine, Spain, Israel, Netherlands, Estonia, Russian Federation, Hungary, Norway, United Kingdom, Slovakia, Latvia
-
AstraZenecaCompletedHypercholesterolemiaSerbia
-
Micropharma LimitedCompletedHypercholesterolemiaCzech Republic
-
AstraZenecaCompleted
-
Ligand PharmaceuticalsWithdrawn
-
AstraZenecaClinart InternationalCompletedHypercholesterolemiaUnited Arab Emirates
-
AstraZenecaCompleted
-
Ottawa Hospital Research InstituteHeart and Stroke Foundation of OntarioCompleted
-
AstraZenecaCompletedHypercholesterolemiaNetherlands
-
Gachon University Gil Medical CenterCompleted
-
Daiichi Sankyo, Inc.CompletedHypercholesterolemiaUnited States, South Africa, Israel, Netherlands, Canada, Norway, Austria, Australia
-
Rambam Health Care CampusUnknown
-
Medical University of GrazCompletedFluvastatin 80 mg Ret. vs Combination With Ezetimibe 10 mg in Patients With High Cardiovascular RiskHypercholesterolemiaAustria
-
Gachon University Gil Medical CenterCompleted
-
DNP CanadaJSS Medical Research Inc.CompletedHypercholesterolemiaCanada